46.46.Z - Wholesale of pharmaceutical goods
46.19.Z - Agents involved in the sale of a variety of goods
47.19.Z - Other retail sale in non-specialised stores
47.78.Z - Other retail sale of new goods in specialised stores
68.20.Z - Rental and operating of own or leased real estate
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
75.00.Z - Veterinary activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,7 | 0,5 | -21 | |
Gross profit (loss) | 0,9 | 0,6 | 0,4 | -21 |
EBITDA | 0,7 | 0,5 | -28,1 | |
Short time liabilities | 2,7 | 2,5 | -8 | |
Other operating costs | 0 | 0 | 282,7 | |
Income tax | 0,1 | -∞ | ||
Equity capital | 2,8 | 3,2 | 3,7 | 13,7 |
Operating profit (EBIT) | 0,7 | 0,5 | -22,6 | |
Assets | 5,6 | 6,5 | 6,9 | 6,4 |
Net profit (loss) | 0,8 | 0,5 | 0,4 | -2,4 |
Cash | 0 | 0 | -38,4 | |
Net income from sale | 8,8 | 4,8 | -45,1 | |
Liabilities and provisions for liabilities | 2,8 | 3,3 | 3,2 | -0,9 |
Working assets | 2,5 | 2,7 | 2 | -28,2 |
Other income costs | 0 | 0 | 0 | |
Depreciation | 0,1 | 0 | -100 | |
Basic operational activity income | 9,4 | 0,8 | ||
% | % | % | p.p. | |
Profitability of capital | 29,5 | 14 | 12 | -2 |
Equity capital to total assets | 50,2 | 49,9 | 53,3 | 3,4 |
Gross profit margin | 10 | 6,4 | 9,2 | 2,8 |
EBITDA Margin | 8 | 10,5 | 2,5 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 112 | 188 | 76 | |
Current financial liquidity indicator | 1.0186587572097778 | 0.7947314381599426 | -0,2 | |
Net dept to EBITDA | 2.0915145874023438 | 2.4469802379608154 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane